BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17076936)

  • 1. Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats.
    Bouwmeester H; Gerrits MA; Roozemond JG; Snapper J; Ronken E; Kruse CG; Westenberg HG; van Ree JM
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):727-39. PubMed ID: 17076936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Age-related changes in behavior, in monoamines and their metabolites content, and in density of D1 and D2 dopamine receptors in the brain structures of WAG/Rij rats with depression-like pathology].
    Sarkisova KY; Kulikov MA; Kudrin VS; Midzyanovskaya IS; Birioukova LM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2014; 64(6):668-85. PubMed ID: 25975143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral metabolic consequences in the adult brain after neonatal excitotoxic lesions of the amygdala in rats.
    Gerrits MA; Wolterink G; van Ree JM
    Eur Neuropsychopharmacol; 2006 Jul; 16(5):358-65. PubMed ID: 16356694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions.
    Hori T; Subramaniam S; Srivastava LK; Quirion R
    Neuropharmacology; 2000 Sep; 39(12):2478-91. PubMed ID: 10974332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of one-week ethanol treatment on monoamine levels and dopaminergic receptors in rat striatum.
    Vasconcelos SM; Macêdo DS; Lima LO; Sousa FC; Fonteles MM; Viana GS
    Braz J Med Biol Res; 2003 Apr; 36(4):503-9. PubMed ID: 12700829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopamine receptors in rats displaying long-term behavioural sensitization to morphine.
    Nestby P; Schotte A; Janssen PF; Tjon GH; Vanderschuren LJ; De Vries TJ; Mulder AH; Leysen JE; Schoffelmeer AN
    Synapse; 1997 Nov; 27(3):262-5. PubMed ID: 9329160
    [No Abstract]   [Full Text] [Related]  

  • 7. Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat.
    Zavitsanou K; Dalton VS; Walker AK; Weickert CS; Sominsky L; Hodgson DM
    Synapse; 2013 Jun; 67(6):290-9. PubMed ID: 23389966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats.
    Schneider M; Koch M
    Exp Neurol; 2005 Sep; 195(1):185-98. PubMed ID: 15935347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
    Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
    Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness.
    Scornaiencki R; Cantrup R; Rushlow WJ; Rajakumar N
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1195-208. PubMed ID: 19275776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
    Rouillon C; Abraini JH; David HN
    Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems.
    Zarrindast MR; Mahboobi S; Sadat-Shirazi MS; Ahmadi S
    J Psychopharmacol; 2011 Jan; 25(1):131-40. PubMed ID: 20685770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both long and brief maternal separation produces persistent changes in tissue levels of brain monoamines in middle-aged female rats.
    Arborelius L; Eklund MB
    Neuroscience; 2007 Mar; 145(2):738-50. PubMed ID: 17222517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Links between temperamental dimensions and brain monoamines in the rat.
    Ray J; Hansen S; Waters N
    Behav Neurosci; 2006 Feb; 120(1):85-92. PubMed ID: 16492119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system.
    Zarrindast MR; Sroushi A; Bananej M; Vousooghi N; Hamidkhaniha S
    Eur J Pharmacol; 2011 Dec; 672(1-3):106-12. PubMed ID: 21968140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of aging and social isolation on changes in brain monoamine turnover and biosynthesis of rats elicited by novelty stress.
    Miura H; Qiao H; Ohta T
    Synapse; 2002 Nov; 46(2):116-24. PubMed ID: 12211090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic administration of risperidone in a rat model of schizophrenia: a behavioural, morphological and molecular study.
    Castellano O; Arji M; Sancho C; Carro J; Riolobos AS; Molina V; Gómez-Nieto R; de Anchieta de Castro E Horta J; Herrero-Turrión MJ; López DE
    Behav Brain Res; 2013 Apr; 242():178-90. PubMed ID: 23291154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide.
    Landa L; Jurajda M; Sulcova A
    Neuro Endocrinol Lett; 2012; 33(4):446-52. PubMed ID: 22936253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.